Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT04011176 · ClinicalTrials.gov registry record · NA
Microcurrent Treatment for Chronic Debilitating Pain
A NA study, sponsored by Paul Crawford.
- Completed
- Registry status
- NA
- Development phase
- 200
- Enrollment target
NCT04011176: Completed NA study, sponsored by Paul Crawford.
NCT04011176 is a NA study that has completed, run by Paul Crawford. The registered enrollment target is 200 participants, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (86% lower). According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT04011176, a NA study, has completed, sponsored by Paul Crawford.
- COMPLETED
- Registry status
- NA
- Development phase
- 200 participants
- Enrollment target
Study Summary
To compare the efficacy of standard pain treatment and placebo (a microcurrent faux treatment) as opposed to standard pain treatment and microcurrent therapy in any primary care patients over a three month period.
Primary Outcome
PROMIS measures provide a common metric: the T-score (mean = 50, standard deviation = 10). In most cases 50 equals the mean in the U.S. general population. PROMIS-57 is a collection of 8-item short forms assessing anxiety, depression, fatigue, pain interference, physical function, sleep disturbance, and ability to participate in social roles and activities as well as a single pain intensity item.
Interventions
- PROCEDURE Standard treatment + placebo
- PROCEDURE Standard treatment + Microcurrent Therapy
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 200 participants |
| Start Date | 2019-12-09 |
| Est. Completion | 2022-06-01 |
| Phase | NA |
What the finished NCT04011176 record still lists
NCT04011176 is an interventional study that assigns participants to a tested intervention. The registered 200 participants enrollment target is mid-sized for trials with a published cap, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (86% lower).
The record links to 0 conditions, and to 2 interventions - of which Standard treatment + placebo is the first listed.
NCT04011176 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT04011176 about?
NCT04011176 is a clinical study titled "Microcurrent Treatment for Chronic Debilitating Pain". To compare the efficacy of standard pain treatment and placebo (a microcurrent faux treatment) as opposed to standard pain treatment and microcurrent therapy in any primary care patients over a three month period.
What is the current status of trial NCT04011176?
This trial is currently completed. It is a NA study. The enrollment target is 200 participants. The study started on 2019-12-09. Estimated completion is 2022-06-01.
What interventions are being tested in trial NCT04011176?
The interventions under investigation include: Standard treatment + placebo (PROCEDURE), Standard treatment + Microcurrent Therapy (PROCEDURE).
Who is sponsoring clinical trial NCT04011176?
This trial is sponsored by Paul Crawford, which has 6 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
How this trial's enrollment target compares
Where NCT04011176's enrollment target sits among peer trials
200 506th of 2000 higher than 1,434 of 2,000 other NA trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other NA trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT00107289 · 200 participants · Phase 2
Iodine I 131 Metaiodobenzylguanidine in Treating Patients With Recurrent, Progressive, or Refractory Neuroblastoma or Malignant Pheochromocytoma or Paraganglioma
- NCT00109174 · 200 participants · NA
MRS Measurement of Glutamate and GABA Metabolism in Brain
- NCT00177268 · 200 participants
Blood, Urine, and Tissue Collection for Cutaneous Lymphoma, Eczema, and Atopic Dermatitis Research
- NCT00493688 · 200 participants
A Study to Determine Whether Perioperative Energy Dynamics Correlates With Postoperative Outcomes
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI